Patients with NB with tumors containing a single copy of MYCN usually have a favorable prognosis, whereas amplification and/or MYCN overexpression are closely associated with rapid disease progression and a high mortality rate [12]. The gene discussed is MYCN; the disease is neuroblastoma.